Cloned Livestock Poised To Receive FDA Clearance
By Jane Zhang, John Miller, and Lauren Etter,
Wall Street Journal
| 01. 04. 2008
Get ready for a food fight over milk and meat from cloned animals and their offspring.
After more than six years of wrestling with the question of whether meat and milk from them are safe to eat, the Food and Drug Administration is expected to declare as early as next week that they are.
The FDA had asked producers of cloned livestock not to sell food products from such animals pending its ruling on their safety. It isn't clear whether the FDA will lift this voluntary hold.
While many consumer groups still oppose it, the FDA declaration that cloned animal products are safe would be a milestone for a small cadre of biotech companies that want to make a business out of producing copies of prize dairy cows and other farm animals -- effectively taking the selective breeding practiced on farms for centuries to the cutting edge.
Because of the price tag -- cloned cattle cost $15,000 to $20,000 per copy -- most of the cloned animals will be used for breeding, and it will be three to five years...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...